A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease

Clinical trial NCT00078611 · COMPLETED

Trial details

NCT number: NCT00078611
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2004-03-01
Primary completion: 2005-03-01
Enrollment: 462

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.